Total Voting Rights

Summary by AI BETAClose X

Polar Capital Global Healthcare Trust plc has announced its total voting rights as of December 31, 2025. The company has 124,149,256 ordinary shares in issue, with 29,707,282 held in treasury, resulting in a total of 94,441,974 voting rights. This figure will serve as the denominator for shareholders calculating their notification requirements under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

Polar Capital Global Health Tst PLC
02 January 2026
 

Polar Capital Global Healthcare Trust plc

Legal Entity Identifier: 549300YV7J2TWLE7PV84

 

 

02 January 2026

 

 

Total Voting Rights

 

In conformity with the FCA's Disclosure Guidance and Transparency Rules, Polar Capital Global Healthcare Trust plc notifies that (the 'Company') had the following Ordinary shares of 25 pence each:

 

31 December 2025

 

Number of Ordinary Shares in issue      

124,149,256

Number of Ordinary Shares held in treasury (non-voting)

29,707,282

Total Voting Rights of the Company

94,441,974

 

Therefore, the total voting rights above may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information, please contact:

 

 

Jumoke Kupoluyi

Director

Polar Capital Secretarial Services

Corporate Secretary

Telephone Number: 020 7227 2700

 

 

 

  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100